Prof. Pankaj R. Shah, India
Anti MICA antibody (major histocompatibility complex class i related chain a) whether to treat or avoid?

Prof. Bilkay Basturk, Turkey
Investigation of miRNA and anti HLA antibodies correlation in patients with kidney transplant

Maria Jesus Citores Sanchez, Spain
Toll-like receptor 9 -1486C/T genetic polymorphism is associated with hepatocarcinoma recurrence after liver transplantation

Dr. Akinbami R. Adenugba, Germany
Predicting early viral control under DAA therapy for chronic HCV using pretreatment immunological markers

Ms. Maria Iglesias Escudero, Spain
CD8 T effector memory t cells as predictive biomarker of severe acute rejection in lung transplantation

Dr. Chuanhui Peng, P.R. China
Hypoxia induced ANKRD37 promotes angiogenesis and reprograms glucose metabolism in hepatocellular carcinoma following liver transplantation

Prof. Christine S. Falk, Germany
Ex vivo lung perfusion using the portable OCS maintains endothelial integrity in the context of reduced severe PGD rates

Dr. Mariana A Seija II, Uruguay
Presence of pre-existing HLA antibodies in renal transplant patients and its impact during the first year post transplant

Dr. Elizabeth Sarmiento, Spain
Defining secondary antibody deficiency after heart transplantation

Mrs. Ikram Ezzahouri, Spain
Mannose binding lectin (mbl2) genotype frequencies in solid organ transplant patients

Prof. Carla C. Baan, Netherlands
Donor-derived cell-free DNA as minimally invasive tool to diagnose acute rejection after kidney transplantation

Dr. Hee Jung Jeon, Korea
VDJ gene usage among B-Cell Receptors in ABO-incompatible kidney transplantation determined by RNA-seq transcriptomic analysis

Dr. Paloma Leticia Martin Moreno, Spain
Developing a rationale for an appropriate immunosuppressive regimen in lung vs kidney transplant recipients.

Ms. Aneta Pletkova, Czech Republic
Association of increased peripheral transitional B cells and plasmablasts with long-term kidney graft survival

Ms. Patricia Conde -San Román, Spain
Targeting trained immunity promotes organ transplant acceptance

Prof. Jose Ignacio Rodriguez-Barbaso, Spain
NK cells regulate CD8 t cell-mediated allogeneic rejection in immunocompetent recipients across an MHC class i mismatched barrier

Mrs. Yuri Cho, Korea
The effect of bisphosphonates on dendritic cells

Dr. Hong Chee Chew, Australia
Ischaemic tolerance and the effect of ageing using a rodent donation after circulatory death (DCD) model

Dr. Maria Eugenia Cornide Petronio, Spain
The protective effect of ischemic preconditioning and HMGB1 in steatotic liver grafts from brain-dead donors submitted to transplant

Dr. Ahmer M Hameed, Australia
Intra-renal delivery of drugs targeting ischemia-reperfusion injury of the kidney using normothermic machine perfusion

Dr. Ling Gao, Australia
Potential limitation for the use of cyclosporine a as a cardioprotective agent during donor heart retrieval and storage

Daniel G. Maluf, United States
Stereotyped molecular response during liver and kidney ischemia/reperfusion injury

Dr. Seth J Concors, United States
Histone deacetylase- 11 gene deletion is protective in renal ischemia-reperfusion injury

Wei Li, P.R. China
Effects of ulinastatin on liver warm ischemia reperfusion injury in mice

Dr. Nicholas L Robbins, United States
Prevention of ischemia-reperfusion injury and chronic rejection in a porcine vascularized composite allotransplantation model

Prof. Jong Soo Lee, Korea
CD137L signaling is an inflammation checkpoint in renal inflammation

Prof. Kee-Hwan Kim, Korea
Activation of autophagy by everolimus confers hepatoprotection against ischemia–reperfusion injury

Dr. María J Barahona, United States
Prevention of ischemic injury in colon and small intestine in an ex vivo perfusion animal model: The role of l-arginine and nutraceutical nanoparticles

Prof. Faikah Gueler, Germany
Ischemia reperfusion injury (IRL) causes local release of free heme which aggravates inflammation and contributes to delayed graft function

Mr. Alexandre Lopez, France
Changes of glycocalyx in steatotic liver graft preservation with UW, HTK and IGL-1 solutions

Dr. Elke Eggenhofer, Germany
Targeting innate immune cells and regulated cell death in early hepatic ischemia reperfusion injury

Mr. Julian Doricic, Germany
Dietary omega-3 food supplementation to attenuate renal ischemia reperfusion injury

Dr. Tina Rubic-Schneider, Switzerland
Anti-CD40 antibodies do not cause thromboembolism as demonstrated by in vitro and in vivo studies

Mr. Jae-Ghi Lee, Korea
Human CD49dhighCD4+ T Cells have characteristics of innate-memory t cells and can help immunoglobulin production of B1 cells

Miss Fleur S Peters, Netherlands
High intragenic methylation of SERPINB9, a regulator of cytotoxicity, in T cells as a marker for skin cancer after kidney transplantation

Dr. Kazuya Kabei, Japan
The new role of HIF-1 in the development of renal fibrosis in mouse UUO model

Mr. Jesus M. Sierra Parraga, Netherlands
Renal intra-arterial delivery of MSC to ischemic porcine kidneys: Retainment, localization and survival

Dr. Daniel Skuk, Canada
Sarcolemmal complement membrane attack complex deposits during acute rejection of myofibers in nonhuman primates

Dr. Jonathan Lakey, United States
Use of flow cytometry to characterize the in vivo development of neonatal porcine islets